ca-0721.pdf
1 de 1
http://www.medicinacomplementar.com.br/convertido/ca-0721.htm
Vitamina K2 efeito benéfico no carcinoma hepatocelular quando em
conjunto com outros tratamentos
13/12/10
Clinical application of vitamin K for hepatocellular carcinoma
[Article in Japanese]
Mizuta T, Ozaki I. Clin Calcium. 2007 Nov;17(11):1693-9.
Saga Medical School, Department of Internal Medicine.
Abstract
Despite recent progress in diagnosis and therapy, hepatocellular carcinoma (HCC) remains among the cancers with the poorest
prognoses. Vitamin K (VK) have been shown to suppress the growth of HCC cells. Long-term administration of VK(2) has established
its clinical safety, but it does not appear to exhibit marked anti-tumor effects when administered alone. For more effective use of VK
against HCC, co-administration of VK(2) with other proven anticancer agents or development of a new VK preparation with a modified
side-chain should be investigated in the future.
PMID: 17982189
7/10/2011 11:51